NASDAQ:NOVT - Novanta Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $99.50
  • Forecasted Upside: -25.97 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$134.40
▲ +1.15 (0.86%)
1 month | 3 months | 12 months
Get New Novanta Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NOVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NOVT

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$99.50
▼ -25.97% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Novanta in the last 3 months. The average price target is $99.50, with a high forecast of $109.00 and a low forecast of $90.00. The average price target represents a -25.97% upside from the last price of $134.40.
Hold
The current consensus among 3 polled investment analysts is to hold stock in Novanta.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/1/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/30/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/13/2020Berenberg BankInitiated CoverageHold$109.00Low
i
5/13/2020Robert W. BairdBoost Price TargetNeutral$80.00 ➝ $90.00High
i
4/2/2020William BlairDowngradeOutperform ➝ Market PerformHigh
i
Rating by B. Drab at William Blair
2/28/2019Robert W. BairdBoost Price TargetNeutral ➝ Neutral$61.00 ➝ $81.00Low
i
5/9/2018Robert W. BairdDowngradeOutperform ➝ Neutral$54.00Low
i
3/1/2018Robert W. BairdReiterated RatingBuyLow
i
2/27/2018William BlairInitiated CoverageOutperform ➝ OutperformLow
i
Rating by B. Drab at William Blair
12/7/2017Robert W. BairdInitiated CoverageOutperform ➝ Outperform$54.00High
i
(Data available from 1/22/2016 forward)
Novanta logo
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The company's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless, recorder and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. Its Precision Motion segment offers optical and inductive encoders, precision motors, motion control sub-assemblies, servo drives, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Lincoln Laser, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, Celera Motion, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.
Read More

Today's Range

Now: $134.40
$132.17
$135.54

50 Day Range

MA: $124.05
$117.68
$133.25

52 Week Range

Now: $134.40
$66.44
$135.54

Volume

142,400 shs

Average Volume

102,613 shs

Market Capitalization

$4.73 billion

P/E Ratio

115.86

Dividend Yield

N/A

Beta

1.09

Frequently Asked Questions

What sell-side analysts currently cover shares of Novanta?

The following Wall Street analysts have issued stock ratings on Novanta in the last twelve months: Berenberg Bank, Robert W. Baird, TheStreet, William Blair, and Zacks Investment Research.

What is the current price target for Novanta?

2 Wall Street analysts have set twelve-month price targets for Novanta in the last year. Their average twelve-month price target is $99.50, suggesting a possible downside of 26.0%. Berenberg Bank has the highest price target set, predicting NOVT will reach $109.00 in the next twelve months. Robert W. Baird has the lowest price target set, forecasting a price of $90.00 for Novanta in the next year.

What is the current consensus analyst rating for Novanta?

Novanta currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NOVT, but not buy more shares or sell existing shares.

What other companies compete with Novanta?

How do I contact Novanta's investor relations team?

Novanta's physical mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company's listed phone number is 781-266-5700 and its investor relations email address is [email protected] The official website for Novanta is www.novanta.com.